The report features an extensive study of thecurrent scenario and future potential of the custom synthesis, modification andpurification services market for oligonucleotides, which are intended forresearch, diagnostic, and therapeutic applications. The study includes in-depth analyses,highlighting the capabilities of service providers engaged in this domain. Inaddition to other elements, it includes:
§ A detailed review ofthe current status of the market with respect to oligonucleotide manufacturersfocused on research and diagnostic, and therapeutic applications.
§ A competitivenessanalysis of prominent oligonucleotide manufacturers, featuring insightfulpictorial summaries and representations.
§ Elaborate profiles ofkey players that offer a diverse range of capabilities for custom synthesis,modification and purification of oligonucleotides.
§ An analysis of thevarious partnerships pertaining to oligonucleotide manufacturing, which havebeen established in the recent past.
§ An analysis of thevarious expansion initiatives undertaken by service providers engaged in thisdomain.
§ A detailed analysisof completed, ongoing and planned clinical research studies of variousoligonucleotide-based drug products.
§ An estimate of theoverall, annual capacity for manufacturing oligonucleotides based on datareported by industry stakeholders in the public domain.
§ An informed estimateof the annual clinical and commercial demand for oligonucleotides.
§ A discussion onaffiliated trends, key drivers and challenges, under an elaborate SWOTframework.
§ A survey analysisfeaturing inputs solicited from various experts who are directly / indirectlyinvolved in providing custom synthesis, modification and purification servicesfor oligonucleotides.
§ A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)
- Type of Manufacturing
§ Custom Manufacturing
§ Large-scale Manufacturing
- Type of Oligonucleotides Manufactured
§ Antisense Oligonucleotides
§ miRNAs
§ shRNAs
§ siRNAs
§ OtherOligonucleotides
- Scale of Operation
§ Clinical
§ Commercial
- Purpose of Production
§ In-house
§ Outsourced
- Target Therapeutic Area
§ Autoimmune Disorders
§ Cardiovascular Disorders
§ Genetic Disorders
§ Infectious Diseases
§ Metabolic Disorders
§ Neuromuscular Disorders
§ Oncological Disorders
§ Ophthalmic Disorders
§ Other Therapeutic Areas
- Size of manufacturer
§ Small
§ Mid-sized
§ Large
- Key Geographical Region
§ NorthAmerica
§ Europe
§ Asia-Pacific and Restof the World
§ Transcripts ofinterviews held with the following senior level representatives of stakeholdercompanies
§ Joachim Bertram (ChiefScientific Officer and Managing Director, IBA Lifesciences)
§ Tobias Pohlmann (Founderand Managing Director, BianoScience)
Key companies coveredin the report
§ Agilent Technologies
§ Ajinomoto Bio-Pharma Services
§ BioSpring
§ CordenPharma
§ Integrated DNA Technologies
§ Kaneka Eurogentec
§ LGC Biosearch Technologies
§ Microsynth
§ Nitto Denko Avecia
§ Sigma Aldrich
§ Thermo Fisher Scientific
§ Trilink Biotechnologies
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html
Other Recent Offerings
1. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
2. Pharmaceutical Continuous Manufacturing Market, 2020-2030
3. PeptideTherapeutics: Contract API Manufacturing Market, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
